SS-31 (Elamipretide)
A tetrapeptide that selectively targets the inner mitochondrial membrane. Currently in Phase III clinical trials for heart failure and kidney disease - the strongest clinical evidence of any mitochondrial peptide.
People use this for
Benefit Profile
SS-31 (Elamipretide)'s fingerprint across categories
Community Interest
Report volume over 12 months
Reported Benefits
3 of 3Mitochondrial Protection
Strongly Positive"SS-31 has noticeably improved my cellular energy. Less fatigue, better recovery, clearer thinking. This one has real clinical data behind it."
Cardioprotection
Positive"Post-cardiac event recovery. Cardiologist is impressed with my progress. Adding SS-31 to my protocol was a good decision."
Anti-Aging Effects
Positive"Energy levels of my 30s returned. Sleep quality improved. This is the most science-backed longevity peptide out there."
Reported Side Effects
Minor irritation at injection site.
Rare, transient nausea.
Dosing Patterns
Most Popular: SubQ at 5 mg
70% of community members report using this dosing protocol 2x weekly. Individual responses vary — start low and adjust based on your experience.
Commonly Stacked With
Frequently Asked
SS-31 (also called Elamipretide or Bendavia) is a tetrapeptide with Phase III clinical trials for heart failure and kidney disease. It protects the inner mitochondrial membrane from oxidative damage. Most clinically validated mitochondrial peptide available.